Table 1

Phase 2 impact on GI

Formulation

GI

% Change from white bread control

P Value

Control

59.3 ± 24.7

1500 mg Capsule

61.9 ± 2.6

-4.39

0.77

2000 mg Capsule

45.1 ± 14.2

24.01

0.076

3000 mg Capsule

46.8 ± 12.5

21.05

0.11

1500 mg Powder

43.6 ± 15.7

26.41

0.11

2000 mg Powder

45.2 ± 14.1

23.76

0.16

3000 mg Powder

39.1 ± 20.2

34.11

0.023

The GI of white bread control compared to the GI of white bread plus different doses and formulations of Phase 2. GI values are presented as mean ± SD, n = 13. P values are the result of comparisons between the control and treatment values.

Udani et al. Nutrition Journal 2009 8:52   doi:10.1186/1475-2891-8-52